Name
Osaühing Paldiski Perearstid
Registry code
10872936
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.06.2002 (22)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Galina Komarova 14.11.1952 (71) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Svetlana Grišina 13.12.1953 (70) | - | - | - | Founder |
| 2019 02.08.2020 | 2020 08.02.2021 | 2021 30.06.2022 | 2022 30.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 264 356 € | 313 172 € | 347 736 € | 373 147 € |
| Net profit (loss) for the period | 27 723 € | 45 022 € | 73 077 € | 86 550 € |
| Profit Margin | 10% | 14% | 21% | 23% |
| Current Assets | 67 089 € | 85 485 € | 139 004 € | 222 305 € |
| Fixed Assets | 920 € | 42 034 € | 31 436 € | 21 248 € |
| Total Assets | 68 009 € | 127 519 € | 170 440 € | 243 553 € |
| Current Liabilities | 26 973 € | 34 178 € | 34 088 € | 50 926 € |
| Non Current Liabilities | 0 € | 28 591 € | 23 525 € | 0 € |
| Total Liabilities | - | 62 769 € | 57 613 € | - |
| Share Capital | - | - | - | - |
| Equity | 41 036 € | 64 750 € | 112 827 € | 192 627 € |
| Employees | 7 | 8 | 8 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 26 902.97 € | 23 135.48 € | 9 |
| 2023 Q4 | - | 18 970.69 € | 19 278.83 € | 9 |
| 2023 Q3 | - | 18 774.11 € | 19 042.59 € | 8 |
| 2023 Q2 | - | 18 824.48 € | 18 123.56 € | 8 |
| 2023 Q1 | - | 17 392.29 € | 17 522.22 € | 7 |
| 2022 Q4 | - | 18 643.85 € | 17 898.56 € | 7 |
| 2022 Q3 | - | 17 392.29 € | 17 522.22 € | 7 |
| 2022 Q2 | - | 19 695.58 € | 19 856.36 € | 7 |
| 2022 Q1 | - | 18 919.44 € | 18 750.56 € | 8 |
| 2021 Q4 | - | 24 070.49 € | 20 138.36 € | 8 |
| 2021 Q3 | - | 18 777.26 € | 19 188.41 € | 8 |
| 2021 Q2 | - | 17 751.03 € | 18 198.84 € | 8 |
| 2021 Q1 | - | 21 444.66 € | 21 996.68 € | 8 |
| 2020 Q4 | - | 21 477.93 € | 22 030.71 € | 9 |
| 2020 Q3 | - | 20 071.59 € | 20 505.98 € | 9 |
| 2020 Q2 | - | 23 126.81 € | 20 106.86 € | 8 |
| 2020 Q1 | - | 18 385.71 € | 18 761.37 € | 8 |
